CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $370,000 | +138.7% | 310,123 | +259.6% | 0.00% | – |
| Q2 2022 | $155,000 | -37.8% | 86,243 | +35.9% | 0.00% | -100.0% |
| Q3 2019 | $249,000 | -61.7% | 63,476 | +75.4% | 0.00% | -71.4% |
| Q4 2018 | $650,000 | -23.2% | 36,184 | +25.7% | 0.01% | +75.0% |
| Q3 2018 | $846,000 | -44.4% | 28,794 | +55.1% | 0.00% | -94.4% |
| Q3 2017 | $1,522,000 | +163.8% | 18,567 | +202.3% | 0.07% | +184.0% |
| Q2 2017 | $577,000 | -84.4% | 6,141 | -92.6% | 0.02% | +4.2% |
| Q4 2016 | $3,687,000 | -38.3% | 83,014 | -49.9% | 0.02% | -42.9% |
| Q3 2016 | $5,975,000 | +691.4% | 165,737 | +1919.2% | 0.04% | +366.7% |
| Q3 2015 | $755,000 | +257.8% | 8,208 | +76.8% | 0.01% | +200.0% |
| Q3 2014 | $211,000 | – | 4,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |